PHVS · Pharvaris N.V. Ordinary Shares
View on chartInsiders & Stakes
| Berndt Modig Chief Executive Officer | ▲ Buy | Option Exercise | 650,000 Shares held | 9/17/2026 | View profile |
| Johannes Gerardus Christiaan Petrus Schikan | ▼ Sell | Open Market | 115,167 Shares held | 9/22/2026 | View profile |
| David W. Nassif CFO / CLO | ▼ Sell | Gift | 113,800 Shares held | 9/21/2026 | View profile |
| Peng Lu Chief Medical Officer | ▲ Buy | Option Exercise | 110,261 Shares held | 9/22/2026 | View profile |
| Anne Lesage Chief Early Development | ▼ Sell | Open Market | 73,969 Shares held | 9/17/2026 | View profile |
| Anna Nijdam Principal Accounting Officer | ▼ Sell | Open Market | 46,275 Shares held | 6/4/2026 | View profile |
| Stefan Andreas Abele Chief Technical Ops Officer | ▼ Sell | Open Market | 39,068 Shares held | 9/15/2026 | View profile |
| Wim Souverijns Chief Commercial Officer | ▼ Sell | Open Market | 39,021 Shares held | 9/15/2026 | View profile |
| Elisabeth Bjork | ▼ Sell | Open Market | 15,167 Shares held | 9/17/2026 | View profile |
| Robert Glassman | ▼ Sell | Open Market | 10,500 Shares held | 9/17/2026 | View profile |
| Viviane Monges Director | ▼ Sell | Open Market | 5,500 Shares held | 9/23/2026 | View profile |
Transaction History
| Viviane Monges | ▲ Buy | Option Exercise | 11,969 | $96K | 9/23/2026 |
| Viviane Monges | ▼ Sell | Open Market | 11,969 | $396K | 9/23/2026 |
| Peng Lu | ▲ Buy | Option Exercise | 45,308 | $117K | 9/22/2026 |
| Johannes Gerardus Christiaan Petrus Schikan | ▲ Buy | Option Exercise | 800 | $16K | 9/22/2026 |
| Johannes Gerardus Christiaan Petrus Schikan | ▼ Sell | Open Market | 800 | $29K | 9/22/2026 |
| David W. Nassif | ▼ Sell | Open Market | 6,000 | $219K | 9/21/2026 |
| David W. Nassif | ▼ Sell | Gift | 500 | $0 | 9/21/2026 |
| Peng Lu | ▲ Buy | Option Exercise | 100,000 | $259K | 9/17/2026 |
| Peng Lu | ▼ Sell | Open Market | 100,000 | $3.5M | 9/17/2026 |
| Johannes Gerardus Christiaan Petrus Schikan | ▼ Sell | Open Market | 200,000 | $7.0M | 9/17/2026 |
| Elisabeth Bjork | ▲ Buy | Option Exercise | 35,000 | $504K | 9/17/2026 |
| Elisabeth Bjork | ▲ Buy | Option Exercise | 17,500 | $317K | 9/17/2026 |
| Elisabeth Bjork | ▼ Sell | Open Market | 52,500 | $2.0M | 9/17/2026 |
| Robert Glassman | ▲ Buy | Option Exercise | 14,493 | $263K | 9/17/2026 |
| Robert Glassman | ▼ Sell | Open Market | 14,493 | $559K | 9/17/2026 |
| Anne Lesage | ▼ Sell | Open Market | 20,000 | $765K | 9/17/2026 |
| Berndt Modig | ▲ Buy | Option Exercise | 300,000 | $10.5M | 9/17/2026 |
| Stefan Andreas Abele | ▲ Buy | Option Exercise | 45,000 | $738K | 9/15/2026 |
| Stefan Andreas Abele | ▼ Sell | Open Market | 45,000 | $1.7M | 9/15/2026 |
| Stefan Andreas Abele | ▼ Sell | Open Market | 1,400 | $55K | 9/15/2026 |
| Robert Glassman | ▲ Buy | Option Exercise | 8,667 | $193K | 9/15/2026 |
| Robert Glassman | ▼ Sell | Open Market | 8,667 | $332K | 9/15/2026 |
| Wim Souverijns | ▼ Sell | Open Market | 6,090 | $237K | 9/15/2026 |
| Wim Souverijns | ▲ Buy | Option Exercise | 20,000 | $349K | 9/14/2026 |
| Wim Souverijns | ▼ Sell | Open Market | 20,000 | $786K | 9/14/2026 |
| Peng Lu | ▼ Sell | Tax Withholding | 117 | $4K | 9/14/2026 |
| Berndt Modig | ▼ Sell | Open Market | 2,291 | $90K | 9/14/2026 |
| Peng Lu | ▲ Buy | Option Exercise | 15,000 | $39K | 9/11/2026 |
| Peng Lu | ▼ Sell | Open Market | 15,000 | $602K | 9/11/2026 |
| Peng Lu | ▼ Sell | Tax Withholding | 109 | $4K | 9/11/2026 |
| Anne Lesage | ▲ Buy | Option Exercise | 30,000 | $242K | 9/10/2026 |
| Anne Lesage | ▼ Sell | Open Market | 30,000 | $1.1M | 9/10/2026 |
| Robert Glassman | ▲ Buy | Option Exercise | 8,000 | $160K | 9/9/2026 |
| Robert Glassman | ▼ Sell | Open Market | 8,000 | $300K | 9/9/2026 |
| Peng Lu | ▲ Buy | Option Exercise | 15,000 | $39K | 9/8/2026 |
| Peng Lu | ▼ Sell | Open Market | 15,000 | $610K | 9/8/2026 |
| Berndt Modig | ▼ Sell | Open Market | 2,292 | $80K | 8/14/2026 |
| Peng Lu | ▼ Sell | Tax Withholding | 117 | $4K | 8/12/2026 |
| Peng Lu | ▼ Sell | Tax Withholding | 109 | $4K | 8/11/2026 |
| Berndt Modig | ▼ Sell | Open Market | 2,292 | $80K | 7/13/2026 |
| Peng Lu | ▼ Sell | Tax Withholding | 117 | $4K | 7/12/2026 |
| Peng Lu | ▼ Sell | Tax Withholding | 109 | $4K | 7/11/2026 |
| Johannes Gerardus Christiaan Petrus Schikan | ▼ Sell | Open Market | 30,712 | $1.1M | 6/30/2026 |
| Anne Lesage | ▲ Buy | Option Exercise | 2,972 | $8K | 6/30/2026 |
| Anne Lesage | ▲ Buy | Option Exercise | 24,900 | $200K | 6/30/2026 |
| Anne Lesage | ▼ Sell | Open Market | 30,703 | $1.1M | 6/30/2026 |
| Anne Lesage | ▼ Sell | Open Market | 27,872 | $989K | 6/30/2026 |
| Johannes Gerardus Christiaan Petrus Schikan | ▼ Sell | Open Market | 6,888 | $241K | 6/29/2026 |
| Anne Lesage | ▲ Buy | Option Exercise | 1,400 | $4K | 6/29/2026 |
| Anne Lesage | ▲ Buy | Option Exercise | 900 | $7K | 6/29/2026 |
| Anne Lesage | ▲ Buy | Option Exercise | 4,100 | $11K | 6/29/2026 |
| Anne Lesage | ▲ Buy | Option Exercise | 4,200 | $34K | 6/29/2026 |
| Anne Lesage | ▼ Sell | Open Market | 2,300 | $81K | 6/29/2026 |
| Anne Lesage | ▼ Sell | Open Market | 8,300 | $291K | 6/29/2026 |
| Anne Lesage | ▼ Sell | Open Market | 6,997 | $245K | 6/29/2026 |
| Johannes Gerardus Christiaan Petrus Schikan | ▼ Sell | Open Market | 2,400 | $84K | 6/29/2026 |
| Peng Lu | ▼ Sell | Open Market | 14,700 | $500K | 6/26/2026 |
| Peng Lu | ▲ Buy | Option Exercise | 14,700 | $38K | 6/26/2026 |
| Anne Lesage | ▲ Buy | Option Exercise | 1,400 | $4K | 6/25/2026 |
| Anne Lesage | ▲ Buy | Option Exercise | 900 | $7K | 6/25/2026 |
| Anne Lesage | ▼ Sell | Open Market | 2,300 | $81K | 6/25/2026 |
| Anne Lesage | ▼ Sell | Open Market | 2,300 | $81K | 6/25/2026 |
| Peng Lu | ▲ Buy | Option Exercise | 15,000 | $39K | 6/25/2026 |
| Peng Lu | ▼ Sell | Open Market | 3,400 | $119K | 6/25/2026 |
| Peng Lu | ▼ Sell | Open Market | 11,600 | $400K | 6/25/2026 |
| Peng Lu | ▲ Buy | Option Exercise | 300 | $777 | 6/18/2026 |
| Peng Lu | ▼ Sell | Open Market | 300 | $10K | 6/18/2026 |
| Berndt Modig | ▼ Sell | Open Market | 2,191 | $68K | 6/15/2026 |
| Berndt Modig | ▼ Sell | Open Market | 100 | $3K | 6/15/2026 |
| Peng Lu | ▼ Sell | Tax Withholding | 117 | $4K | 6/12/2026 |
| Peng Lu | ▼ Sell | Tax Withholding | 109 | $3K | 6/11/2026 |
| Anna Nijdam | ▼ Sell | Open Market | 2,670 | $82K | 6/4/2026 |
| Anna Nijdam | ▲ Buy | Option Exercise | 5,501 | $110K | 5/22/2026 |
| Anna Nijdam | ▼ Sell | Open Market | 5,501 | $169K | 5/22/2026 |
| Viviane Monges | ▼ Sell | Open Market | 9,667 | $293K | 5/21/2026 |
| Anna Nijdam | ▲ Buy | Option Exercise | 1,829 | $37K | 5/21/2026 |
| Anna Nijdam | ▼ Sell | Open Market | 1,829 | $56K | 5/21/2026 |
| David W. Nassif | ▼ Sell | Open Market | 10,000 | $303K | 5/21/2026 |
| Elisabeth Bjork | ▲ Buy | Option Exercise | 10,000 | $81K | 5/20/2026 |
| Elisabeth Bjork | ▼ Sell | Open Market | 10,000 | $293K | 5/20/2026 |
| Berndt Modig | ▼ Sell | Open Market | 2,292 | $67K | 5/18/2026 |
| Robert Glassman | ▲ Buy | Option Exercise | 5,333 | $119K | 5/15/2026 |
| Robert Glassman | ▼ Sell | Open Market | 5,333 | $159K | 5/15/2026 |
| Robert Glassman | ▼ Sell | Open Market | 4,667 | $139K | 5/15/2026 |
| Stefan Andreas Abele | ▼ Sell | Open Market | 8,748 | $261K | 5/15/2026 |
| Wim Souverijns | ▼ Sell | Open Market | 10,000 | $299K | 5/15/2026 |
| Peng Lu | ▼ Sell | Tax Withholding | 117 | $4K | 5/12/2026 |
| Peng Lu | ▼ Sell | Tax Withholding | 109 | $3K | 5/11/2026 |
| Peng Lu | ▲ Buy | Option Exercise | 14,166 | $37K | 5/1/2026 |
| Peng Lu | ▼ Sell | Open Market | 14,023 | $423K | 5/1/2026 |
| Peng Lu | ▼ Sell | Open Market | 143 | $4K | 5/1/2026 |
| Johannes Gerardus Christiaan Petrus Schikan | ▼ Sell | Open Market | 28,400 | $861K | 4/30/2026 |
| Anne Lesage | ▲ Buy | Option Exercise | 3,700 | $10K | 4/30/2026 |
| Anne Lesage | ▼ Sell | Open Market | 3,700 | $112K | 4/30/2026 |
| Anne Lesage | ▲ Buy | Option Exercise | 18,000 | $145K | 4/30/2026 |
| Anne Lesage | ▼ Sell | Open Market | 18,000 | $545K | 4/30/2026 |
| Anne Lesage | ▼ Sell | Open Market | 19,200 | $581K | 4/30/2026 |
| Johannes Gerardus Christiaan Petrus Schikan | ▼ Sell | Open Market | 670 | $21K | 4/30/2026 |
| Peng Lu | ▲ Buy | Option Exercise | 15,000 | $39K | 4/30/2026 |
| Peng Lu | ▼ Sell | Open Market | 15,000 | $454K | 4/30/2026 |
| Johannes Gerardus Christiaan Petrus Schikan | ▼ Sell | Open Market | 3,830 | $115K | 4/29/2026 |
| Peng Lu | ▼ Sell | Open Market | 3,733 | $112K | 4/29/2026 |
| Anne Lesage | ▲ Buy | Option Exercise | 3,700 | $10K | 4/29/2026 |
| Anne Lesage | ▼ Sell | Open Market | 3,700 | $111K | 4/29/2026 |
| Anne Lesage | ▼ Sell | Open Market | 3,700 | $111K | 4/29/2026 |
| Peng Lu | ▲ Buy | Option Exercise | 3,733 | $10K | 4/29/2026 |
| Anne Lesage | ▼ Sell | Open Market | 100 | $3K | 4/23/2026 |
| Anne Lesage | ▲ Buy | Option Exercise | 100 | $259 | 4/23/2026 |
| Anne Lesage | ▼ Sell | Open Market | 100 | $3K | 4/23/2026 |
| Peng Lu | ▼ Sell | Open Market | 100 | $3K | 4/23/2026 |
| Peng Lu | ▲ Buy | Option Exercise | 100 | $259 | 4/23/2026 |
| Johannes Gerardus Christiaan Petrus Schikan | ▼ Sell | Open Market | 100 | $3K | 4/23/2026 |
| Anne Lesage | ▼ Sell | Open Market | 7,000 | $210K | 4/22/2026 |
| Peng Lu | ▲ Buy | Option Exercise | 7,001 | $18K | 4/22/2026 |
| Peng Lu | ▼ Sell | Open Market | 7,001 | $210K | 4/22/2026 |
| Johannes Gerardus Christiaan Petrus Schikan | ▼ Sell | Open Market | 7,000 | $210K | 4/22/2026 |
| Anne Lesage | ▲ Buy | Option Exercise | 500 | $1K | 4/22/2026 |
| Anne Lesage | ▼ Sell | Open Market | 500 | $15K | 4/22/2026 |
| Anne Lesage | ▲ Buy | Option Exercise | 7,000 | $56K | 4/22/2026 |
| Anne Lesage | ▼ Sell | Open Market | 7,000 | $210K | 4/22/2026 |
| Peng Lu | ▼ Sell | Tax Withholding | 226 | $7K | 4/16/2026 |
| Berndt Modig | ▼ Sell | Open Market | 2,292 | $66K | 4/16/2026 |
| Anna Nijdam | ▼ Sell | Tax Withholding | 548 | $15K | 4/11/2026 |
| Berndt Modig | ▼ Sell | Open Market | 23,133 | $642K | 4/9/2026 |
| Berndt Modig | ▼ Sell | Open Market | 200 | $6K | 4/9/2026 |
| Anna Nijdam | ▼ Sell | Tax Withholding | 1,167 | $33K | 4/6/2026 |
| Anna Nijdam | ▼ Sell | Tax Withholding | 1,164 | $33K | 4/1/2026 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Pharvaris publishes Phase 3 deucrictibant data in The Lancet
Pharvaris reported Phase 3 results for deucrictibant IR in The Lancet, showing symptom relief in 1.28 hours and complete resolution in 11.95 hours for HAE attacks. The company stated that the New Drug Application and Marketing Authorization Application are currently under review. Additional real-world data on patient preferences was also published, providing context for the treatment strategy.
Pharvaris publishes Phase 3 deucrictibant data in The Lancet. Pharvaris reported Phase 3 results for deucrictibant IR in The Lancet, showing symptom relief in 1.28 hours and complete resolution in 11.95 hours for HAE attacks. The company stated that the New Drug Application and Marketing Authorization Application are currently under review. Additional real-world data on patient preferences was also published, providing context for the treatment strategy.